Graft versus host disease (GvHD) is a major complication following allogeneic hematopoietic stem cell transplantation (allo-SCT) and related to immunological reactions mainly mediated by donor CD3+ T cells of the CD8+ subset and directed against host tissues [1]. Here, CD8A is linked to graft versus host disease.